{
    "title": "115_hr1271",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``DXM Abuse Prevention Act of 2017''.\n\nSEC. 2. SALES OF OVER-THE-COUNTER DRUGS CONTAINING DEXTROMETHORPHAN.\n\n    (a) Prohibited Acts.--\n            (1) Verification system.--Section 301 of the Federal Food, \n        Drug, and Cosmetic Act (21 U.S.C. 331) is amended by adding at \n        the end the following:\n    ``(eee) The failure of a retailer (as defined in section 506H) that \noffers for sale in interstate commerce covered drugs (as defined in \nsection 506H) to have a verification system as required by section 506H \n(relating to sales of over-the-counter drugs containing \ndextromethorphan).''.\n            (2) Identifier for electronic point of sale system; active \n        ingredients.--Section 301 of the Federal Food, Drug, and \n        Cosmetic Act (21 U.S.C. 331), as amended by paragraph (1), is \n        further amended by adding at the end the following:\n    ``(fff) The introduction or delivery for introduction into \ninterstate commerce of any covered drug (as defined in section 506H) \nwhose labeling does not include--\n            ``(1) a universal product code, universal product number, \n        bar code, or similar identifier to allow an electronic point of \n        sale system to recognize that the sale of the covered drug is \n        prohibited to those under the age of 18; and\n            ``(2) the established name of each active ingredient of the \n        covered drug within the first panel of the drug facts labeling \n        required by section 201.66(c) of title 21, Code of Federal \n        Regulations (or any successor regulations), in no smaller than \n        6-point type.''.\n    (b) Verification System.--The Federal Food, Drug, and Cosmetic Act \nis amended by inserting after section 506G of such Act (21 U.S.C. 356g) \nthe following:\n\n``SEC. 506H. SALES OF OVER-THE-COUNTER DRUGS CONTAINING \n              DEXTROMETHORPHAN.\n\n    ``(a) Verification System.--Any retailer selling or offering for \nsale in interstate commerce a covered drug shall have a verification \nsystem in accordance with this section that is intended to ensure that \nno individual who purchases a covered drug from the retailer is under \n18 years of age. Such a system shall be set up to prompt a retailer to \nexamine a purchaser's identification card.\n    ``(b) Means Used To Ensure Compliance.--A verification system under \nsubsection (a) may ensure compliance with this section by any of, or \nany combination of, the following means:\n            ``(1) An electronic point-of-sale system that is coded--\n                    ``(A) to prompt for verification of the age of \n                purchasers of covered drugs; and\n                    ``(B) to deny sales of covered drugs to those under \n                the age of 18.\n            ``(2) Training manuals, materials, or programs that \n        instruct employees--\n                    ``(A) to verify the age of purchasers of covered \n                drugs; and\n                    ``(B) to deny sales of covered drugs to those under \n                the age of 18.\n            ``(3) Signage in and around the sales counter outlining the \n        age restriction on sales of covered drugs.\n            ``(4) Designating one on-duty employee to approve sales of \n        covered drugs.\n            ``(5) Any other verification measure adopted by a retailer \n        that is designed to ensure that a purchaser of a covered drug \n        is not under 18 years of age if, based on an examination of the \n        purchaser's identification card, the retailer reasonably \n        concludes the identification card is valid and indicates the \n        purchaser is not under 18 years of age.\n    ``(c) Exceptions.--\n            ``(1) Individuals over 26.--A verification system under \n        subsection (a) need not require verification of the age of any \n        individual over the age of 26.\n            ``(2) Valid prescription.--A verification system under \n        subsection (a) need not apply to any sale made by a retailer \n        that is a pharmacy pursuant to a validly issued prescription.\n            ``(3) Valid military identification card.--A verification \n        system under subsection (a) need not apply to any sale to an \n        individual who supplies proof at the time of such sale that \n        such individual is actively enrolled in the military and \n        presents a valid military identification card.\n    ``(d) Enforcement.--In carrying out this section, the Secretary \nshall coordinate with State entities that regulate retailers, as \ndesignated by the State, to perform activities to ensure compliance \nwith this section, including providing for appropriate investigation of \ncomplaints related to violations of this section.\n    ``(e) Compliance With State System.--If a State has a law under \nwhich a retailer in the State is required to have a system that ensures \nthat no individual who purchases a covered drug from the retailer is \nunder 18 years of age, the Secretary shall treat any such retailer in \nthe State that is in compliance with such law as having a verification \nsystem as required by this section, including for purposes of sections \n301(eee) and 303(h).\n    ``(f) Definitions.--In this section:\n            ``(1) The term `covered drug'--\n                    ``(A) means a drug that--\n                            ``(i) contains dextromethorphan; and\n                            ``(ii) is not subject to section 503(b)(1); \n                        and\n                    ``(B) excludes any drug that is packaged in packets \n                or pouches and contains 2 or fewer maximum adult doses \n                of dextromethorphan as allowable under section 341.74 \n                of title 21, Code of Federal Regulations (or any \n                successor regulations).\n            ``(2) The term `identification card' means an \n        identification card that--\n                    ``(A) includes a photograph and the date of birth \n                of the individual; and\n                    ``(B) is issued by a State or the Federal \n                Government or is considered acceptable for purposes of \n                sections 274a.2(b)(1)(v)(A) and 274a.2(b)(1)(v)(B)(1) \n                of title 8, Code of Federal Regulations (including any \n                successor regulations).\n            ``(3) The term `retailer' means--\n                    ``(A) a grocery store, general merchandise store, \n                drug store, pharmacy, convenience store, or other \n                entity whose activities as a seller of covered drugs \n                containing dextromethorphan are limited almost \n                exclusively to sales for personal use, both in number \n                and volume of sales, including any sales made by the \n                Internet or other means; and\n                    ``(B) excludes any entity listed in subparagraph \n                (A) that does not sell any covered drug described in \n                paragraph (1)(A).''.\n    (c) Civil Penalties.--Section 303 of the Federal Food, Drug, and \nCosmetic Act (21 U.S.C. 333) is amended by adding at the end the \nfollowing:\n    ``(h) A retailer that violates section 301(eee) shall not be \nsubject to subsection (a) or any civil monetary penalty under this Act \nfor such violation except as follows:\n            ``(1) If the Secretary finds that a retailer fails to have \n        a verification system in violation of section 301(eee)--\n                    ``(A) upon the first such finding, the Secretary \n                shall issue a formal notice of violation and give the \n                retailer a period of at least 30 days (beginning on the \n                receipt of such notice) to correct the violation;\n                    ``(B) upon the second such finding, the retailer \n                shall be subject to a civil penalty of not more than \n                $1,000;\n                    ``(C) upon the third such finding, the retailer \n                shall be subject to a civil penalty of not more than \n                $2,000; and\n                    ``(D) upon the fourth and any subsequent such \n                finding, the retailer shall be subject to a civil \n                penalty of not more than $5,000.\n            ``(2) In determining the amount of a civil penalty under \n        this subsection for a retailer, the Secretary shall consider \n        whether the retailer has taken appropriate steps to prevent \n        subsequent violations, such as the establishment and \n        administration of a documented employee training program to \n        ensure all employees are familiar with, and abiding by, the \n        retailer's verification system established pursuant to section \n        506H, where such program includes--\n                    ``(A) educating employees regarding covered drugs;\n                    ``(B) instruction on the correct method of checking \n                a purchaser's identification card; and\n                    ``(C) notifying employees of the civil penalties \n                under this subsection.\n            ``(3) If a retailer transacts sales of covered drugs at \n        more than one physical location, for purposes of determining \n        the number of violations by that retailer under this \n        subsection, each individual physical location operated by that \n        retailer shall be considered a separate retailer.\n            ``(4) The Secretary shall notify retailers found to have \n        violated section 301(eee) as soon as practicable after the \n        Secretary discovers such violation. Such notification shall \n        include the date and time when the failure to have a \n        verification system as required by such section was observed to \n        occur.\n            ``(5) In this subsection, the terms `covered drug' and \n        `retailer' have the meanings given such terms in section \n        506H.''.\n    (d) Applicability.--The amendments made by subsections (a), (b), \nand (c) shall apply with respect to drugs sold or offered for sale on \nor after the date that is one year after the date of enactment of this \nAct.\n    (e) Sense of Congress Regarding Communication by Organizations \nNominated by Manufacturers.--It is the sense of Congress that \norganizations nominated by manufacturers of covered drugs (as defined \nin section 506H of the Federal Food, Drug, and Cosmetic Act, as added \nby subsection (c)) should make reasonable efforts to communicate to \nretailers (as defined in such section 506H) the requirements of such \nsection 506H, including by making available upon request materials \n(which may include signage, manuals, materials, or programs) to assist \nwith educating employees regarding such covered drugs.\n\nSEC. 3. RESTRICTIONS ON DISTRIBUTION OF BULK DEXTROMETHORPHAN.\n\n    (a) In General.--The Federal Food, Drug, and Cosmetic Act is \namended--\n            (1) in section 301 (21 U.S.C. 331) (as amended by section \n        2(a)) by adding at the end the following:\n    ``(ggg) The possession, receipt, or distribution of unfinished \ndextromethorphan in violation of section 506I.'';\n            (2) by inserting after section 506H (as added by section \n        2(b)) the following:\n\n``SEC. 506I. RESTRICTIONS ON THE DISTRIBUTION OF BULK DEXTROMETHORPHAN.\n\n    ``(a) In General.--No person shall--\n            ``(1) possess or receive unfinished dextromethorphan, \n        unless the person is registered under section 510 or otherwise \n        registered, licensed, or approved pursuant to Federal or State \n        law to engage in--\n                    ``(A) the practice of pharmacy; or\n                    ``(B) drug or drug ingredient discovery, \n                production, manufacture, or distribution; or\n            ``(2) distribute unfinished dextromethorphan to any person \n        other than a person described in paragraph (1).\n    ``(b) Exception for Common Carriers.--This section does not apply \nto a common carrier that possesses, receives, or distributes unfinished \ndextromethorphan for purposes of distributing such unfinished \ndextromethorphan between persons described in subsection (a).\n    ``(c) Definitions.--In this section:\n            ``(1) The term `common carrier' means any person that holds \n        itself out to the general public as a provider for hire of the \n        transportation by water, land, or air of merchandise, whether \n        or not the person actually operates the vessel, vehicle, or \n        aircraft by which the transportation is provided, between a \n        port or place and a port or place in the United States.\n            ``(2) The term `unfinished dextromethorphan' means \n        dextromethorphan that is not contained in a drug that is in \n        finished dosage form.''; and\n            (3) by amending section 303, as amended by section 2(c), by \n        adding at the end the following:\n    ``(i) A person that violates section 301(ggg) shall not be subject \nto subsection (a) or any civil monetary penalty under this Act for such \nviolation except such person shall be subject to a civil penalty in an \namount of not more than $100,000.''.\n    (b) Applicability.--The amendments made by this section apply \nbeginning on the date of enactment of this Act."
}